ICBMT 2026

HOME

Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

Satellite Symposium 3

Sep. 19 (Sat), 08:30-09:00 		Room C
(2F)
Chair(s) Seok Lee (Ewha Womans University College of Medicine, Korea)
  • Jae-Ho Yoon

    08:30-09:00

    Ph-positive ALL in 2026: From Precision Immuno-targeted Therapy to Transplantation

    Jae-Ho Yoon

    College of Medicine, The Catholic University of Korea, Korea

Joint Symposium 6 (TSBMT-KSBMT)

Endothelial Dysfunction Syndromes after Allogeneic HSCT: From SOS/VOD and TA-TMA to CLS/ES and PRES

Sep. 19 (Sat), 09:00-10:00 		Room A
(1F)
Chair(s) Kyung-Nam Koh (University of Ulsan College of Medicine, Korea)
  • Hakan Göker

    09:00-09:30

    Hepatic, Pulmonary, and Systemic Endothelial Injury after Allogeneic HSCT: SOS/VOD, Capillary Leak/Engraftment Syndrome, and IPS/DAH

    Hakan Göker

    Hacettepe University, Türkiye

  • Suhyun Yoon

    09:30-10:00

    Microvascular and CNS Endothelial Dysfunction (TA-TMA, PRES, GVHD-Related Endothelial Injury)

    Suhyun Yoon

    Korea University College of Medicine, Korea

Scientific Session 9

Insights on GVHD Prediction, Prevention and Management

Sep. 19 (Sat), 10:10-11:40 		Room A
(1F)
Chair(s) Hoon Kook (Chonnam National University Medical School, Korea)
Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea)
  • Kirk Schultz

    10:10-10:40

    Pediatric Chronic GVHD: From Biological Insights to Clinical Management

    Kirk Schultz

    BC Children's Hospital Research Insitutue, Canada

  • Takanori Teshima

    10:40-11:10

    Immunobiology of GVHD Prevention

    Takanori Teshima

    Hokkaido University, Japan

  • Yoo Jin Lee

    11:10-11:40

    Microbiome and GvHD Following Allogeneic HSCT

    Yoo Jin Lee

    University of Ulsan College of Medicine, Korea

Scientific Session 10

Immune Effector Cell Therapy in Lymphoid Malignancies: From Pivotal Trials to Real-World Practice

Sep. 19 (Sat), 10:10-11:40 		Room C
(2F)
Chair(s) Jin Seok Kim (Yonsei University College of Medicine, Korea)
Young Rok Do (Keimyung University School of Medicine, Korea)
  • Jae Park

    10:10-10:40

    Integrating MRD into CAR T-cell Therapy for ALL: from Patient Selection to Post-treatment Intervention

    Jae Park

    Memorial Sloan Kettering Cancer Center, USA

  • Binod Dhakal

    10:40-11:10

    Sequencing Cellular Therapy in Multiple Myeloma: Lessons from Trials and Real-world Practice

    Binod Dhakal

    Medical College of Wisconsin, USA

  • Young Woo Jeon

    11:10-11:40

    Real-world CAR‑T Experience in LBCL

    Young Woo Jeon

    The Catholic University of Korea, Korea

Nursing Session 2 KOR

Sep. 19 (Sat), 10:10-11:10 		Room D
(2F)
Chair(s) Heejun Kim (Samsung Medical Center, Korea)
  • Yang-Gun Suh

    10:10-10:40

    Radiotherapy in Hematologic Malignancies and Stem Cell Transplantation

    Yang-Gun Suh

    National Cancer Center, Korea

  • Kwang-Sung Kim

    10:40-11:10

    Restoring Normal life for Hematology Patients

    Kwang-Sung Kim

    College of Medicine, The Catholic University of Korea, Korea